Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials.
about
New treatments for chronic prostatitis/chronic pelvic pain syndromeGABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic painBupropion for the treatment of neuropathic pain.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Combining opioid and adrenergic mechanisms for chronic pain.Cohort protocol paper: the Pain and Opioids In Treatment (POINT) studyAssociation of mu-opioid and NMDA receptors in the periaqueductal gray: what does it mean for pain control?Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms.Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.Behavioral models of pain states evoked by physical injury to the peripheral nerve.Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature.Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.Peripheral afferents and spinal inhibitory system in dynamic and static mechanical allodynia.Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia.Sensory innervation of the dorsal longitudinal ligament and the meninges in the lumbar spine of the dog.
P2860
Q33721812-13BD13B7-A5A2-4DD7-B668-4C79EDE74881Q33898753-E1C0AC47-5281-4511-AA90-AF82000DD4E6Q34100677-CA83F66E-438D-4DCB-A97C-D8B20F61A2B4Q34110857-7323E876-0C79-44FD-9563-420880DB09D1Q34434307-286EEB9C-1045-4A25-8037-39A0A8D50981Q35124926-12794379-F90B-4804-BAE1-A498338EC6F7Q35622693-025896EA-9E56-4A23-AE85-80A4069131C8Q35935050-072E4E5E-8B44-4EC6-B8EB-358739F027ACQ37283665-B474B409-3777-4CEC-896C-61E1BB8917E2Q37355278-CF457049-0584-420A-A950-B7F4231B0CA7Q37374346-7CA75374-5F91-4718-924A-7D25A906FFA6Q37422699-A11E94E0-88A2-45CD-B403-3DCAEED78B68Q37907386-0ECBB618-D04C-4D08-85BF-8ED223DE98D2Q40901705-9C7355D7-C609-440F-A5EF-7B5FBC443C97Q50198422-369D4722-D33E-49DA-9396-E9EB3AF2CC25Q52629677-E9E267C0-42DA-475D-A51D-6442348861AEQ53056688-7CA1421C-67E0-49F5-9B63-859B58C2C1F5
P2860
Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@ast
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@en
type
label
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@ast
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@en
prefLabel
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@ast
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@en
P2093
P2860
P1476
Efficacy of mu-opioid agonists ...... randomized controlled trials.
@en
P2093
Daniel B Carr
Elon Eisenberg
Ewan D McNicol
P2860
P304
P356
10.1016/J.EJPAIN.2005.10.007
P577
2005-12-05T00:00:00Z